➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Eugia Pharma Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EUGIA PHARMA, and what generic and branded alternatives to EUGIA PHARMA drugs are available?

EUGIA PHARMA has ten approved drugs.

There is one tentative approval on EUGIA PHARMA drugs.

Summary for Eugia Pharma

US Patents:	0
Tradenames:	7
Ingredients:	7
NDAs:	10

Drugs and US Patents for Eugia Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eugia Pharma	LETROZOLE	letrozole	TABLET;ORAL	211717-001	Jan 11, 2019	AB	RX	No	No		Start Trial				Start Trial
Eugia Pharma	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	205487-001	Mar 28, 2016		DISCN	No	No		Start Trial				Start Trial
Eugia Pharma	OXALIPLATIN	oxaliplatin	INJECTABLE;INTRAVENOUS	205529-001	Sep 6, 2017	AP	RX	No	No		Start Trial				Start Trial
Eugia Pharma	METHOTREXATE SODIUM	methotrexate sodium	TABLET;ORAL	210454-001	Jan 30, 2020	AB	RX	No	No		Start Trial				Start Trial
Eugia Pharma	HYDROXYPROGESTERONE CAPROATE	hydroxyprogesterone caproate	SOLUTION;INTRAMUSCULAR	211070-001	Apr 16, 2019	AP1	RX	No	No		Start Trial				Start Trial
Eugia Pharma	HYDROXYPROGESTERONE CAPROATE	hydroxyprogesterone caproate	SOLUTION;INTRAMUSCULAR	211142-001	May 9, 2019		DISCN	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Eugia Pharma

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Colorcon

Harvard Business School

Boehringer Ingelheim

Moodys

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.